These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1870211)

  • 61. Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA.
    Wyatt LS; Whitehead SS; Venanzi KA; Murphy BR; Moss B
    Vaccine; 1999 Oct; 18(5-6):392-7. PubMed ID: 10519927
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines.
    Sakurai H; Williamson RA; Crowe JE; Beeler JA; Poignard P; Bastidas RB; Chanock RM; Burton DR
    J Virol; 1999 Apr; 73(4):2956-62. PubMed ID: 10074145
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neutralization of respiratory syncytial virus after cell attachment.
    Osiowy C; Anderson R
    J Virol; 1995 Feb; 69(2):1271-4. PubMed ID: 7815504
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived.
    Connors M; Collins PL; Firestone CY; Murphy BR
    J Virol; 1991 Mar; 65(3):1634-7. PubMed ID: 1995956
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Respiratory syncytial virus infection in anti-mu-treated mice.
    Graham BS; Bunton LA; Rowland J; Wright PF; Karzon DT
    J Virol; 1991 Sep; 65(9):4936-42. PubMed ID: 1908028
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge.
    Bembridge GP; Lopez JA; Bustos R; Melero JA; Cook R; Mason H; Taylor G
    J Virol; 1999 Dec; 73(12):10086-94. PubMed ID: 10559323
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune response to respiratory syncytial virus: prevention of syncytia formation by human serum during in vitro infection.
    Faden H; Lin T; Hong JJ; Ogra PL
    Pediatr Res; 1984 Oct; 18(10):987-91. PubMed ID: 6387611
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection.
    Weltzin R; Traina-Dorge V; Soike K; Zhang JY; Mack P; Soman G; Drabik G; Monath TP
    J Infect Dis; 1996 Aug; 174(2):256-61. PubMed ID: 8699052
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity.
    Barbas CF; Crowe JE; Cababa D; Jones TM; Zebedee SL; Murphy BR; Chanock RM; Burton DR
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10164-8. PubMed ID: 1279672
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Monoclonal capture antibody ELISA for respiratory syncytial virus: detection of individual viral antigens and determination of monoclonal antibody specificities.
    Hendry RM; Fernie BF; Anderson LJ; Godfrey E; McIntosh K
    J Immunol Methods; 1985 Mar; 77(2):247-58. PubMed ID: 3981003
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.
    Trudel M; Stott EJ; Taylor G; Oth D; Mercier G; Nadon F; Séguin C; Simard C; Lacroix M
    Arch Virol; 1991; 117(1-2):59-71. PubMed ID: 1706591
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.
    Hu KF; Elvander M; Merza M; Akerblom L; Brandenburg A; Morein B
    Clin Exp Immunol; 1998 Aug; 113(2):235-43. PubMed ID: 9717973
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunoglobulin-class-specific immune response to respiratory syncytial virus structural proteins in infants, children, and adults.
    Popow-Kraupp T; Lakits E; Kellner G; Kunz C
    J Med Virol; 1989 Mar; 27(3):215-23. PubMed ID: 2723614
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunity to and frequency of reinfection with respiratory syncytial virus.
    Hall CB; Walsh EE; Long CE; Schnabel KC
    J Infect Dis; 1991 Apr; 163(4):693-8. PubMed ID: 2010624
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections.
    Muelenaer PM; Henderson FW; Hemming VG; Walsh EE; Anderson LJ; Prince GA; Murphy BR
    J Infect Dis; 1991 Jul; 164(1):15-21. PubMed ID: 2056202
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The development of respiratory syncytial virus-specific immune complexes in nasopharyngeal secretions following natural infection.
    Kaul TN; Welliver RC; Faden HS; Ogra PL
    J Clin Lab Immunol; 1984 Dec; 15(4):187-90. PubMed ID: 6527374
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants.
    Murphy BR; Collins PL; Lawrence L; Zubak J; Chanock RM; Prince GA
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2185-90. PubMed ID: 2671259
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9.
    Johnson S; Griego SD; Pfarr DS; Doyle ML; Woods R; Carlin D; Prince GA; Koenig S; Young JF; Dillon SB
    J Infect Dis; 1999 Jul; 180(1):35-40. PubMed ID: 10353858
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Respiratory syncytial virus G-protein modulates cytokine release from human peripheral blood mononuclear cells.
    König B; Streckert HJ; Krusat T; König W
    J Leukoc Biol; 1996 Mar; 59(3):403-6. PubMed ID: 8604019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.